Atlas Trials

Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma With Solitary Huge Tumor

Clinical trial NCT03191123 · UNKNOWN

Trial details

NCT number
NCT03191123
Sponsor
Huazhong University of Science and Technology
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Carcinoma, HepatocellularSurvival Rate
Start date
2016-07-05
Primary completion
2018-07-05
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.